Thornalley Paul J, Rabbani Naila
Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, UK; Warwick Systems Biology Centre, Coventry House, University of Warwick, Coventry CV4 7AL, UK.
Biochim Biophys Acta. 2014 Feb;1840(2):818-29. doi: 10.1016/j.bbagen.2013.03.025. Epub 2013 Apr 2.
Proteins in human tissues and body fluids continually undergo spontaneous oxidation and glycation reactions forming low levels of oxidation and glycation adduct residues. Proteolysis of oxidised and glycated proteins releases oxidised and glycated amino acids which, if they cannot be repaired, are excreted in urine.
In this review we give a brief background to the classification, formation and processing of oxidised and glycated proteins in the clinical setting. We then describe the application of stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC-MS/MS) for measurement of oxidative and glycation damage to proteins in clinical studies, sources of error in pre-analytic processing, corroboration with other techniques - including how this may be improved - and a systems approach to protein damage analysis for improved surety of analyte estimations.
Stable isotopic dilution analysis LC-MS/MS provides a robust reference method for measurement of protein oxidation and glycation adducts. Optimised pre-analytic processing of samples and LC-MS/MS analysis procedures are required to achieve this.
Quantitative measurement of protein oxidation and glycation adducts provides information on level of exposure to potentially damaging protein modifications, protein inactivation in ageing and disease, metabolic control, protein turnover, renal function and other aspects of body function. Reliable and clinically assessable analysis is required for translation of measurement to clinical diagnostic use. Stable isotopic dilution analysis LC-MS/MS provides a "gold standard" approach and reference methodology to which other higher throughput methods such as immunoassay and indirect methods are preferably corroborated by researchers and those commercialising diagnostic kits and reagents. This article is part of a Special Issue entitled Current methods to study reactive oxygen species - pros and cons and biophysics of membrane proteins. Guest Editor: Christine Winterbourn.
人体组织和体液中的蛋白质不断经历自发氧化和糖基化反应,形成低水平的氧化和糖基化加合物残基。氧化和糖基化蛋白质的蛋白水解会释放出氧化和糖基化氨基酸,如果这些氨基酸无法修复,就会随尿液排出。
在本综述中,我们简要介绍了临床环境中氧化和糖基化蛋白质的分类、形成和处理的背景知识。然后,我们描述了稳定同位素稀释分析液相色谱 - 串联质谱法(LC-MS/MS)在临床研究中用于测量蛋白质氧化和糖基化损伤的应用、分析前处理中的误差来源、与其他技术的验证——包括如何改进——以及用于提高分析物估计准确性的蛋白质损伤分析系统方法。
稳定同位素稀释分析LC-MS/MS为测量蛋白质氧化和糖基化加合物提供了一种可靠的参考方法。为此需要对样品进行优化的分析前处理和LC-MS/MS分析程序。
蛋白质氧化和糖基化加合物的定量测量提供了有关潜在有害蛋白质修饰的暴露水平、衰老和疾病中的蛋白质失活、代谢控制、蛋白质周转、肾功能及身体功能其他方面的信息。将测量结果转化为临床诊断用途需要可靠且可临床评估的分析方法。稳定同位素稀释分析LC-MS/MS提供了一种“金标准”方法和参考方法,研究人员以及诊断试剂盒和试剂商业化者最好将其他高通量方法(如免疫测定和间接方法)与之进行验证。本文是名为“研究活性氧的当前方法——利弊与膜蛋白生物物理学”的特刊的一部分。客座编辑:克里斯汀·温特伯恩。